1. The Challenge of Addiction and Hepatitis C Diana Sylvestre, MD University of CA, San Francisco OASIS 2. HCV Prevalence by Selected Groups United States Hemophilia Injection…
Slide 1Treatment and access to treatment in low and middle income countries Adeeba Kamarulzaman University of Malaya Kuala Lumpur, Malaysia ANRS-NIDA Joint Satellite Drug…
Slide 1Recent HCV treatment developments: In pursuit of perfectovir Professor Greg Dore Kirby Institute, UNSW Australia; & St Vincent’s Hospital, Sydney Slide 2 201320112015201220162014…
Slide 1 HCV-HBV co-infection in Russian Federation Chumakov Institute of Poliomyelitis and Viral Encephalitis, Moscow Karen Kyuregyan VIII Annual Conference of New Visby…
Slide 1 Epidemiology and Control Programs for HBV Infection. Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital Slide 2 Slide 3 Epidemiology…
Slide 1 Hepatitis C in Pakistan Rashid A. Chotani Assistant Professor & Director, The Global Infectious Disease Surveillance & Alert System The Johns Hopkins Bloomberg…
Slide 1 Slide 2 Introducing Harm Reduction in Mauritius Emphasizing on the lack of services for Young People Who Inject Drugs Guffran Rostom Head of Department Prevention,…
Slide 1 Washington D.C., USA, 22-27 July 2012www.aids2012.org HCV genotype and HBV co-infection associate with HCV clearance in HIV- positive subjects Yuan Dong, Chao Qiu,…
Slide 1 Renal Transplantation for HIV/HCV Co-infected Patients Solid Organ Transplantation and People With HIV: Ethics and Policy Conference David Oldach & Robert Redfield…
PowerPoint Presentation Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco Washington D.C., USA, 22-27 July 2012 www.aids2012.org…